TARGET DECK: transfusion medicine (obs)

Heavy spin: 5000g for 5 mins #flashcard 
pRBC and Plt conc
<!--ID: 1707306658413-->


Heavy spin: 5000g for 7 mins #flashcard 
cryo and cell free plasma
<!--ID: 1707306658420-->


Light spin: 2000g for 3 mins #flashcard 
PRP
<!--ID: 1707306658425-->


For preparation of PLT conc, centrifugation is done at what temperature. Otherwise, done at what temperature #flashcard 
room temp, 1-6 C
<!--ID: 1707306658430-->

The maximum allowable storage time for RBCs is defined by #flashcard 
the requirement for recovery of 70% of transfused cells 24 hours after transfusion
<!--ID: 1707308721385-->


Additive solution that adds 7 days to the component #flashcard 
AS 1, 3, 5
<!--ID: 1707308721395-->


AS-1 #flashcard 
Adsol
<!--ID: 1707308721400-->


AS-3 #flashcard 
Nutricel
<!--ID: 1707308721404-->


AS-5 #flashcard 
Optisol
<!--ID: 1707308721408-->


Additive solution: suspends solutes #flashcard 
Saline
<!--ID: 1707308721412-->


Additive solution: Improve RBC survival #flashcard 
Adenine
<!--ID: 1707308721415-->


Additive solution: ATP production #flashcard 
Glucose 
<!--ID: 1707308721421-->


Additive solution: RBC stabilizing agent #flashcard 
Mannitol
<!--ID: 1707308721427-->


Used to regenerate ATP and 2,3 DPG #flashcard 
Rejuvenation solutions
<!--ID: 1707308721433-->


Decreased during storage lesion #flashcard 
pH, ATP, 2,3 DPG, Sodium
<!--ID: 1707308721440-->


Increased during storage lesion #flashcard 
Plasma Hgb, and K
<!--ID: 1707308721444-->


PROVIDE BLOOD VOLUME EXPANSION AND RBC MASS IN ACUTE BLOOD LOSS #flashcard 
Whole Blood
<!--ID: 1707308721449-->


INCREASE RBC MASS OF SYMPTOMATIC, NORMOVOLEMIC PATIENTS #flashcard 
PRBC
<!--ID: 1707308721455-->


INCREASE RBC MASS IN PATIENTs WITH SEVERE AND/OR RECURRENT FEBRILE TRANSFUSION REACTIONS DUE TO LEUKOCYTE ANTIBODIES. INCREASE RBC MASS IN PATIENTS AT RISK FOR HLA ALLOIMMUNIZATION TO HLA ANTIGENS OR SUSCPETIBLE TO CMV. #flashcard 
Leukocyte reduced RBCs
<!--ID: 1707308721461-->


INCREASE RBC MASS OF SYMPTOMATIC ANEMIC PATIENTS WITH HISTORY OF ALLERGIC, FEBRILE, URTICARIAL, AND ANAPHYLACTIC #flashcard 
Washed RBC
<!--ID: 1707308721468-->


STORAGE OF RARE BLOOD AND AUTOLOGOUS UNITS #flashcard 
Frozen RBC
<!--ID: 1707308721473-->


BLOOD COMPONENT FOR BLEEDING DUE TO THROMBOCYTOPENIA #flashcard 
PC
<!--ID: 1707308721479-->


PLATELET CONCENTRATES (RDP / Random donor pool) contains ? platelets per unit #flashcard 
5.5x10^10
<!--ID: 1707308721484-->


Washed RBC shelf life #flashcard 
24 hrs
<!--ID: 1707308721490-->


Frozen RBCs shelf life #flashcard 
10 years
<!--ID: 1707308721495-->


PC (RDP) shelf life #flashcard 
5 days
<!--ID: 1707308721501-->


PLATELET CONCENTRATE (SDP / Single donor apheresis pool) contains ? platelets per unit #flashcard 
3x10^11
<!--ID: 1707308721506-->


BLOOD COMPONENT FOR THROMBOCYTOPENIC PATIENTS ALLOIMMUNIZED TO HLA OR PLATELET ANTIGEN #flashcard 
PC (SDP)
<!--ID: 1707308721510-->


Platelet storage temp #flashcard 
20-24 w/ agitation
<!--ID: 1707308721515-->


BLOOD COMPONENT USED TO CORRECT MULTIPLE COAGULATION FACTOR DEFICIENCY #flashcard 
FFP
<!--ID: 1707308721519-->


FFP STORAGE TEMP #flashcard 
-18 OR COLDER
<!--ID: 1707308721523-->


FFP SHELF LIFE #flashcard 
1 YR
<!--ID: 1707308721530-->


FOR TREATMENT OF FIBRINOGEN DEFICIENCY, HEMOPHILIA A,VON WILLEBRANDâ€™S DISEASE AND FACTOR XIII DEFICIENCY #flashcard 
CRYOPRECIPITATE
<!--ID: 1707308721537-->


Cryoprecipitate used for treatment to the ff diseases (4) #flashcard 
1. fibrinogen def
2. Hemophilia A
3. VWD
4. Factor XIII def
<!--ID: 1707308721543-->


CRYOPRECIPITATE STORAGE #flashcard 
-18 OR COLDER
<!--ID: 1707308721549-->


BLOOD COMPONENT FOR PATIENTS WITH GRANULOCYTE DYSFUNCTION OR MYELOID HYPOPLASIA WHO ARE UNRESPONSIVE TO ANTIBIOTICS #flashcard 
GRANULOCYTE PHERESIS
<!--ID: 1707308721554-->



PREVENT OR CONTROL BLEEDING IN HEMOPHILIA A PATIENTS #flashcard 
FACTOR VIII CONCENTRATE
<!--ID: 1707308721559-->


PREVENT OR CONTROL BLEEDING IN HEMOPHILIA B PATIENTS #flashcard 
FACTOR IX CONCENTRATE
<!--ID: 1707308721565-->


REPLACE LOSS OF COLLOIDS IN HYPOVOLEMIC SHOCK, SEVERE BURNS, OR FOR PRESSURE SUPPORT DURING HYPOTENSIVE EPISODES #flashcard 
ALBUMIN, PLASMA PROTEIN FRACTION
<!--ID: 1707308721571-->


Any unfavorable transfusion related event occuring in a patient during or after transfusion of blood component #flashcard 
TRANSFUSION REACTION
<!--ID: 1707309076650-->


A diverse group of adverse reactions to transfusion that usually occur during or shortly after transfusion. #flashcard 
TRANSFUSION REACTION
<!--ID: 1707309076657-->


If a transfusion reaction occurs while transfusion is in progress, the transfusion should be stopped IMMEDIATELY, and the intravenous line should be kept open with ? #flashcard 
SALINE
<!--ID: 1707309076662-->


IMMEDIATE IMMUNE TRANSFUSION REACTION mnemonic: FATAI #flashcard 
IHTR 
FNHTR 
ALLERGIC TR 
ANAPHYLACTIC/ANAPHYLACTOID 
TRALI
<!--ID: 1707309076666-->


DELAYED IMMUNE TRANSFUSION REACTION hint: D sa delayed -> mnemo: DAP #flashcard 
DHTR 
ALLOIMMUNIZATION 
PTP
<!--ID: 1707309076671-->

IMMEDIATE NONIMMUNE TR #flashcard 
BACTERIAL CONTAM
TACO
<!--ID: 1707310062602-->


DELAYED NONIMMUNE TR #flashcard 
IRON OVERLOAD
<!--ID: 1707310062606-->


4 COMMON ANTIBODY THAT INDUCE IMMEDIATE HTR #flashcard 
- Anti-A (most common) 
- Anti-Kell 
- Anti-Jka 
- Anti-Fya
<!--ID: 1707310062609-->


Positive DAT and gradual drop in patient's hemoglobin and hematocrit, mild jaundice #flashcard 
Delayed HTR
<!--ID: 1707310062614-->


5 COMMON ANTIBODY THAT INDUCE DELAYED HTR #flashcard 
- RH
- MNS
- KELL
- KIDD
- DUFFY
<!--ID: 1707310062618-->


HTR: INTRAVASCULAR HEMOLYSIS #flashcard 
IMMEDIATE HTR
<!--ID: 1707310062621-->


HTR: EXTRAVASCULAR HEMOLYSIS #flashcard 
DELAYED HTR
<!--ID: 1707310062624-->


Any 1 degrees C temperature rise associated w/ transfusion and having no medical explanation other than blood component transfusion #flashcard 
FNHTR
<!--ID: 1707310062628-->


PREVENTION FOR FNHTR #flashcard 
LEUKOREDUCED BC
<!--ID: 1707310062631-->


The donor plasma has a foreign protein (allergen) w/ which antibodies is present is present in patient plasma react. #flashcard 
ALLERGIC TR
<!--ID: 1707310062636-->


The donor plasma has reagin that react with the allergen present on patient plasma. #flashcard 
ALLERGIC TR
<!--ID: 1707310062640-->


PREVENTION FOR ALLERGIC TR #flashcard 
WASHED RBCS
<!--ID: 1707310062644-->


2 ANAPHYLACTIC TR FEATURES #flashcard 
1. NO FEVER
2. SXN OCCURS AFTER TRANSFUSION AFTER JUST FEW ML OF PLASMA
<!--ID: 1707310062648-->


ANAPHYLACTIC VS ANAPHYLACTOID TR #flashcard 
ANAPHYLACTIC = PX DEF IN IgA
ANAPHYLACTOID = PX normal IgA but a limited type-specific IgA that reacts with the donor's IgA
<!--ID: 1707310062653-->


PREVENTION OF ANAPHYLACTIC/TOID TR #flashcard 
REMOVAL OF PLASMA
<!--ID: 1707310062656-->


Consists of an acute transfusion reaction presenting with respiratory distress and severe hypoxemia during or within 6 hours of transfusion in the absence other causes of acute lung injury. #flashcard 
TRALI
<!--ID: 1707310062662-->


TRALI CAUSED BY #flashcard 
ANTI-LEUKOCYTE ANTIBODY
<!--ID: 1707310062666-->


TRALI PREVENTION #flashcard 
LEUKOREDUCED BC
<!--ID: 1707310062670-->


iatrogenic transfusion reaction, >200 mL/hr rate of transfusion #flashcard 
TACO
<!--ID: 1707310062674-->


most common pathogen of Transfusion associated Sepsis #flashcard 
Y. enterocolitica
<!--ID: 1707310062678-->



Rapid onset of thrombocytopenia as a result of anamnestic production of platelet alloantibody #flashcard 
POST TRANSFUSION PURPURA
<!--ID: 1707310062681-->


PTP LAG TIME #flashcard 
7-14 DAYS
<!--ID: 1707310062686-->


Defined as a delayed immune transfusion reaction due to an immunologic attack by viable donor lymphocyte contained in the transfused blood component against the recipient #flashcard 
TAGVHD
<!--ID: 1707310062689-->


